Literature DB >> 23669800

Renal amyloidosis secondary to rheumatoid arthritis: remission of proteinuria and renal function improvement with tocilizumab.

Juan Pablo Vinicki1, Graciela De Rosa, Hugo A Laborde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23669800     DOI： 10.1097/RHU.0b013e318293793c

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN： 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  7 in total

1.  Tocilizumab-induced remission of nephrotic syndrome accompanied by secondary amyloidosis and glomerulonephritis in a patient with rheumatoid arthritis.

Authors:  Shunsuke Yamada; Akihiro Tsuchimoto; Yoshiki Kaizu; Masatomo Taniguchi; Kosuke Masutani; Hiroshi Tsukamoto; Hiroaki Ooboshi; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  CEN Case Rep       Date:  2014-07-29

2.  Biologic therapy for amyloid A amyloidosis secondary to rheumatoid arthritis treated with interleukin 6 therapy: Case report and review of literature.

Authors:  Ju-Yang Jung; Young-Bae Kim; Ji-Won Kim; Chang-Hee Suh; Hyoun-Ah Kim
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

Review 3.  Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever.

Authors:  Serdal Ugurlu; Aysa Hacioglu; Yasaman Adibnia; Vedat Hamuryudan; Huri Ozdogan
Journal:  Orphanet J Rare Dis       Date:  2017-05-30       Impact factor: 4.123

4.  Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis.

Authors:  Levent Kilic; Abdulsamet Erden; Yusuf Ziya Sener; Berkan Armagan; Alper Sari; Umut Kalyoncu; Omer Karadag; Ali Akdogan; Ismail Dogan; Sule Apras Bilgen; Sedat Kiraz; Ihsan Ertenli
Journal:  Biomolecules       Date:  2018-11-05

Review 5.  Serum Amyloid A Protein-Associated Kidney Disease: Presentation, Diagnosis, and Management.

Authors:  Jordan Thorne; David Clark; Laurette Geldenhuys; Keigan More; Amanda Vinson; Karthik Tennankore
Journal:  Kidney Med       Date:  2022-06-26

6.  The classic signalling and trans-signalling of interleukin-6 are both injurious in podocyte under high glucose exposure.

Authors:  Chun-Tao Lei; Hua Su; Chen Ye; Hui Tang; Pan Gao; Cheng Wan; Fang-Fang He; Yu-Mei Wang; Chun Zhang
Journal:  J Cell Mol Med       Date:  2017-09-07       Impact factor: 5.310

7.  Tocilizumab preserves renal function in rheumatoid arthritis with AA amyloidosis and end-stage kidney disease: Two case reports.

Authors:  Makoto Fukuda; Naoki Sawa; Junichi Hoshino; Kenichi Ohashi; Miyazono Motoaki; Yoshifumi Ubara
Journal:  Clin Nephrol       Date:  2021-01       Impact factor: 0.975
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.